Nika Pharmaceuticals, Inc

President, CEO, CFO, Director, 10% OwnerNIKA PHARMACEUTICALS, INC (NKPH) · full profile →Form 4 · filed Mar 19, 2024
Net Selling
Open-Market Buys
$115K
Open-Market Sells
$433K
Net Open-Market Flow
-$318K
Transactions
9
9 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2023Sell(S)3.5M$0.02$70K
Jan 31, 2023Sell(S)1.5M$0.01$15K
Jan 10, 2023Sell(S)6.3M$0.01$63K
Oct 24, 2022Sell(S)3.0M$0.04$120K
Sep 26, 2022Sell(S)1.3M$0.02$25K
Sep 12, 2022Sell(S)7.0M$0.02$140K
Jul 20, 2022Other(J)333.2M$0
Apr 13, 2022Buy(P)11.5M$0.01$115K
Apr 13, 2022Other(J)10.0M$3000000.00$30.0T10.0M

Transaction Codes

S
Open-market sale
J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001826466-24-000034) within minutes of acceptance. Every field above traces to the original document. Verify it directly: